Teladoc Health, Inc. (NYSE:TDOC – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Wednesday after Piper Sandler lowered their price target on the stock from $25.00 to $10.00. Piper Sandler currently has an overweight rating on the stock. Teladoc Health traded as low as $7.23 and last traded at $7.26, with a volume of 3716442 shares trading hands. The stock had previously closed at $7.49.
Other research analysts also recently issued reports about the company. Barclays reduced their price objective on Teladoc Health from $20.00 to $10.00 and set an “overweight” rating for the company in a research note on Thursday, August 1st. Royal Bank of Canada reduced their price objective on Teladoc Health from $25.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, April 26th. DA Davidson reduced their price objective on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating for the company in a research note on Thursday, August 1st. Evercore ISI reduced their price objective on Teladoc Health from $14.00 to $10.00 and set an “in-line” rating for the company in a research note on Tuesday, July 9th. Finally, Wells Fargo & Company reduced their price objective on Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating for the company in a research note on Monday, April 29th. Fourteen research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $13.56.
Insider Transactions at Teladoc Health
In other news, COO Michael Willem Waters sold 6,053 shares of the stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $49,271.42. Following the completion of the transaction, the chief operating officer now directly owns 74,214 shares in the company, valued at approximately $604,101.96. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, COO Michael Willem Waters sold 6,053 shares of the firm’s stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $49,271.42. Following the completion of the transaction, the chief operating officer now directly owns 74,214 shares in the company, valued at approximately $604,101.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Laizer Kornwasser sold 10,879 shares of the firm’s stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $88,555.06. Following the transaction, the chief executive officer now owns 99,929 shares of the company’s stock, valued at $813,422.06. The disclosure for this sale can be found here. In the last ninety days, insiders sold 37,714 shares of company stock worth $358,714. 0.95% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Teladoc Health
Several hedge funds and other institutional investors have recently made changes to their positions in TDOC. Vanguard Group Inc. boosted its stake in shares of Teladoc Health by 11.8% in the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock valued at $377,451,000 after buying an additional 1,855,480 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of Teladoc Health by 25.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider’s stock valued at $82,636,000 after buying an additional 767,999 shares during the period. Norges Bank purchased a new position in shares of Teladoc Health in the 4th quarter valued at about $9,714,000. Pale Fire Capital SE purchased a new position in shares of Teladoc Health in the 4th quarter valued at about $8,960,000. Finally, Mizuho Markets Americas LLC purchased a new position in shares of Teladoc Health in the 2nd quarter valued at about $3,937,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.
Teladoc Health Stock Down 4.4 %
The firm has a 50 day moving average price of $9.73 and a 200-day moving average price of $13.43. The company has a current ratio of 3.82, a quick ratio of 3.74 and a debt-to-equity ratio of 0.67. The firm has a market cap of $1.21 billion, a PE ratio of -5.13 and a beta of 0.93.
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.